Literature DB >> 24889057

Development and maintenance of a biospecimen repository for clinical samples derived from pulmonary patients.

Lisa M Schwiebert1, Kim Estell, Tonja Meadows, Victor J Thannickal, Steven Rowe, Eric J Sorscher, W Thomas Harris, Amit Gaggar, Mark Dransfield, Joao A de Andrade.   

Abstract

The Pulmonary Biospecimen Repository (PBR) at the University of Alabama at Birmingham (UAB) was launched in 2009. The purpose of the UAB PBR is to provide investigators within the pulmonary community at UAB and elsewhere with clinical samples derived from multiple lung diseases, including transplant recipients, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Cell and fluid samples isolated from bronchoalveolar lavage (BAL), plasma, and serum are collected and stored; samples are assessed routinely for viability. Each sample is linked directly with the respective patient information via the Pulmonary Translational Research and Clinical Database, a Health Insurance Portability and Accountability Act compliant database that includes detailed information allowing for the study of specific patient cohorts. To access samples, investigators must complete a request form, which is reviewed by the UAB PBR Steering Committee. To date, more than 800 patients have provided approximately 7,000 BAL, serum and plasma fluid, and cell samples. Over the past 4 years, nearly 800 of these samples have been distributed to investigators at UAB and elsewhere. Future plans for the UAB PBR include expanding sample collection to additional pulmonary diseases, such as mycobacterial infections, increasing the number of sample users and obtaining external funding to ensure its continued sustainability.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  biospecimens; lung; repository

Mesh:

Year:  2014        PMID: 24889057      PMCID: PMC5439804          DOI: 10.1111/cts.12161

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  8 in total

1.  Economic burden of impairment in children with severe or difficult-to-treat asthma.

Authors:  Stanley J Szefler; Robert S Zeiger; Tmirah Haselkorn; David R Mink; Tripthi V Kamath; James E Fish; Bradley E Chipps
Journal:  Ann Allergy Asthma Immunol       Date:  2011-06-02       Impact factor: 6.347

2.  Elevated levels of NO are localized to distal airways in asthma.

Authors:  John T Anderson; Meiqin Zeng; Qian Li; Ryan Stapley; Doyle Ray Moore; Balachandra Chenna; Naomi Fineberg; Jaroslaw Zmijewski; Isam-Eldin Eltoum; Gene P Siegal; Amit Gaggar; Stephen Barnes; Sadanandan E Velu; Victor J Thannickal; Edward Abraham; Rakesh P Patel; Jack R Lancaster; David D Chaplin; Mark T Dransfield; Jessy S Deshane
Journal:  Free Radic Biol Med       Date:  2011-03-16       Impact factor: 7.376

3.  Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells.

Authors:  Lisa M Schwiebert; William C Rice; Brian A Kudlow; Amanda L Taylor; Erik M Schwiebert
Journal:  Am J Physiol Cell Physiol       Date:  2002-02       Impact factor: 4.249

4.  Absence, extended absence, and repeat tardiness related to asthma status among elementary school children.

Authors:  Samina S Mizan; Derek G Shendell; George G Rhoads
Journal:  J Asthma       Date:  2011-02-21       Impact factor: 2.515

5.  Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Authors:  Timothy S Blackwell; Andrew M Tager; Zea Borok; Bethany B Moore; David A Schwartz; Kevin J Anstrom; Ziv Bar-Joseph; Peter Bitterman; Michael R Blackburn; William Bradford; Kevin K Brown; Harold A Chapman; Harold R Collard; Gregory P Cosgrove; Robin Deterding; Ramona Doyle; Kevin R Flaherty; Christine Kim Garcia; James S Hagood; Craig A Henke; Erica Herzog; Cory M Hogaboam; Jeffrey C Horowitz; Talmadge E King; James E Loyd; William E Lawson; Clay B Marsh; Paul W Noble; Imre Noth; Dean Sheppard; Julie Olsson; Luis A Ortiz; Thomas G O'Riordan; Tim D Oury; Ganesh Raghu; Jesse Roman; Patricia J Sime; Thomas H Sisson; Daniel Tschumperlin; Shelia M Violette; Timothy E Weaver; Rebecca G Wells; Eric S White; Naftali Kaminski; Fernando J Martinez; Thomas A Wynn; Victor J Thannickal; Jerry P Eu
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

6.  COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population.

Authors:  Monica J Fletcher; Jane Upton; Judith Taylor-Fishwick; Sonia A Buist; Christine Jenkins; John Hutton; Neil Barnes; Thys Van Der Molen; John W Walsh; Paul Jones; Samantha Walker
Journal:  BMC Public Health       Date:  2011-08-01       Impact factor: 3.295

7.  The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  Gerard J Nuovo; James S Hagood; Cynthia M Magro; Nena Chin; Rubina Kapil; Luke Davis; Clay B Marsh; Virginia A Folcik
Journal:  Mod Pathol       Date:  2011-10-28       Impact factor: 7.842

8.  Feasibility of exercising adults with asthma: a randomized pilot study.

Authors:  Amy Boyd; Celeste T Yang; Kim Estell; Craig Tuggle Ms; Lynn B Gerald; Mark Dransfield; Marcas Bamman; James Bonner; T Prescott Atkinson; Lisa M Schwiebert
Journal:  Allergy Asthma Clin Immunol       Date:  2012-08-03       Impact factor: 3.406

  8 in total
  1 in total

Review 1.  Open-access biorepository for idiopathic pulmonary fibrosis. The way forward.

Authors:  Eric S White; Kevin K Brown; Harold R Collard; Craig S Conoscenti; Gregory P Cosgrove; Kevin R Flaherty; Jonathan A Leff; Fernando J Martinez; Jesse Roman; Dan Rose; Shelia Violette; Naftali Kaminski
Journal:  Ann Am Thorac Soc       Date:  2014-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.